About China Pharma (NYSEAMERICAN:CPHI)
China Pharma Holdings, Inc. is a holding company. The Company conducts its production, marketing, finance, development and administrative activities through its subsidiary, Hainan Helpson Medical & Biotechnology Co., Ltd. (Helpson) in the People's Republic of China (PRC). It is engaged in the development, manufacture and marketing of pharmaceutical products for human use in connection with various diseases and medical conditions in the PRC. It manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, oral solutions and granules. Its pharmaceutical products are sold on a prescription basis and are approved by the China Food and Drug Administration (the CFDA). The Company manufactured over 20 pharmaceutical products for various diseases and medical indications. It offers products for Central Nervous System (CNS) and Cerebral-Cardiovascular Diseases, Anti-infection and Respiratory Diseases, Digestive Diseases and Others.
Industry, Sector and Symbol
Industry Biotechnology & Medical Research
Trailing P/E Ratio-2.05
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on Equity-15.43%
Return on Assets-11.58%
China Pharma (NYSEAMERICAN:CPHI) Frequently Asked Questions
What is China Pharma's stock symbol?
China Pharma trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CPHI."
How were China Pharma's earnings last quarter?
China Pharma Holdings, Inc. (NYSEAMERICAN:CPHI) released its quarterly earnings results on Wednesday, November, 15th. The company reported ($0.05) earnings per share for the quarter. The firm had revenue of $3.16 million for the quarter. China Pharma had a negative net margin of 69.43% and a negative return on equity of 15.43%. During the same quarter in the previous year, the company earned ($0.04) EPS. View China Pharma's Earnings History.
When will China Pharma make its next earnings announcement?
Are investors shorting China Pharma?
China Pharma saw a increase in short interest in December. As of December 15th, there was short interest totalling 129,548 shares, an increase of 71.6% from the November 30th total of 75,477 shares. Based on an average daily trading volume, of 106,655 shares, the days-to-cover ratio is presently 1.2 days. Currently, 0.6% of the shares of the company are short sold.
Who are some of China Pharma's key competitors?
Some companies that are related to China Pharma include ReNeuron Group (RENE), Vernalis (VER), OvaScience (OVAS), Caladrius Biosciences (CLBS), AEterna Zentaris (AEZS), Scancell (SCLP), Can Fite Biopharma (CANF), Oncobiologics (ONS), Repros Therapeutics (RPRX), Prana Biotechnology (PRAN), Bio-Path (BPTH), Genocea Biosciences (GNCA), Fibrocell Science (FCSC), OHR Pharmaceutical (OHRP), Burcon NutraScience (BUR), OncoGenex Pharmaceuticals (ACHV), Jaguar Health (JAGX) and Yield10 Bioscience (YTEN).
Who are China Pharma's key executives?
China Pharma's management team includes the folowing people:
- Zhilin Li, Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer (Age 61)
- Heung Mei Tsui, Director (Age 57)
- Gene Michael Bennett, Independent Director (Age 67)
- Baowen Dong, Independent Director (Age 73)
- Yingwen Zhang, Independent Director (Age 69)
How do I buy China Pharma stock?
Shares of China Pharma can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is China Pharma's stock price today?
One share of China Pharma stock can currently be purchased for approximately $0.41.
How big of a company is China Pharma?
China Pharma has a market capitalization of $21.46 million.
How can I contact China Pharma?
China Pharma's mailing address is 2Nd Floor, No. 17, Jinpan Road, Haikou, HAIKOU, HAN 570216, China. The company can be reached via phone at +86-898-66811730.
MarketBeat Community Rating for China Pharma (CPHI)MarketBeat's community ratings are surveys of what our community members think about China Pharma and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
China Pharma (NYSEAMERICAN:CPHI) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
China Pharma (NYSEAMERICAN:CPHI) Earnings History and Estimates Chart
China Pharma (NYSEAMERICAN CPHI) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|11/15/2017||Q3 17||($0.05)||$3.16 million||View||N/A|
|8/15/2017||Q2 2017||($0.05)||$2.92 million||View||N/A|
|5/12/2017||Q1 17||($0.02)||$3.29 million||View||N/A|
|11/15/2016||Q316||($0.04)||$26.78 million||$3.10 million||View||N/A|
|8/11/2016||Q216||($0.06)||$26.78 million||$3.50 million||View||N/A|
|5/17/2016||Q116||($0.04)||$26.78 million||$3.60 million||View||N/A|
|11/17/2015||Q315||($0.10)||$26.78 million||$4.80 million||View||N/A|
|8/14/2015||Q215||($0.09)||$26.78 million||$5.70 million||View||N/A|
|5/12/2015||Q115||($0.18)||$26.78 million||$5.70 million||View||N/A|
|3/31/2015||Q4 2014||($0.20)||$6.13 million||View||N/A|
|8/15/2014||Q2 14||($0.20)||$8.00 million||$6.10 million||View||N/A|
|5/15/2014||Q114||($0.05)||$8.20 million||$7.10 million||View||N/A|
|11/15/2013||Q313||($0.05)||$12.20 million||$8.10 million||View||N/A|
China Pharma (NYSEAMERICAN:CPHI) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for China Pharma (NYSEAMERICAN:CPHI)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for China Pharma (NYSEAMERICAN CPHI)
No insider trades for this company have been tracked by MarketBeat.com
China Pharma (NYSEAMERICAN CPHI) News Headlines
|China Pharma Holdings, Inc. (CPHI) Short Interest Up 71.6% in December|
www.americanbankingnews.com - December 27 at 7:24 PM
|Walgreens Boots Alliance (WBA) Enters Pact to Reduce Stake in Guangzhou Pharmaceuticals Corporation|
www.streetinsider.com - December 22 at 9:19 AM
|China Pharma Holdings, Inc. :CPHI-US: Earnings Analysis: Q3, 2017 By the Numbers : December 1, 2017|
finance.yahoo.com - December 1 at 4:32 PM
|China, Hong Kong stocks fall on caution after N.Korea missile test|
www.reuters.com - November 29 at 9:10 AM
|China Pharma Holdings, Inc. (CPHI) Short Interest Update|
www.americanbankingnews.com - November 27 at 9:56 PM
|Conavi Medical and China Grand Pharmaceutical and Healthcare Enter into Distribution Agreement for Minimally Invasive Imaging Technologies in China|
www.businesswire.com - November 16 at 6:07 PM
|EARNINGS SUMMARY: Details of China Pharma Holdings Inc. Q3 Earnings Report|
www.rttnews.com - November 16 at 6:07 PM
|China Pharma Holdings' (CPHI) CEO Zhilin Li on Q3 2017 Results - Earnings Call Transcript|
seekingalpha.com - November 16 at 6:07 PM
|China Pharma Holdings, Inc. Reports Third Quarter 2017 Financial Results|
finance.yahoo.com - November 16 at 1:03 PM
|China Pharma Holdings, Inc. (CPHI) Announces Quarterly Earnings Results|
www.americanbankingnews.com - November 16 at 9:44 AM
|Temasek Holdings (private) Ltd Buys Visa Inc, Virtu Financial Inc, Ctrip. ...|
www.nasdaq.com - November 15 at 4:51 AM
China Pharma (NYSEAMERICAN:CPHI) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
China Pharma (NYSEAMERICAN CPHI) Stock Chart for Thursday, January, 18, 2018